Johannes Van Dijk

Johannes van Dijk is a highly experienced scientist specializing in metabolic engineering and strain optimization within the biotechnology sector. Currently serving as a Senior Scientist at Debut since February 2022, Johannes is responsible for developing implementation plans for complex projects, pushing strain performance for economic viability, and utilizing CRISPR-Cas9 technology for advancing bacterial microbes. Previously, Johannes held positions at DSM and Zymergen, Inc., where contributions included leading teams in high-throughput microbial strain optimization and developing novel food enzyme products. Academic credentials include a PhD in Pharmaceutical Sciences from the University of Southern California and multiple degrees in Molecular Bioengineering and Biomedical Engineering from Eindhoven University of Technology, complemented by diverse roles in research and education.